@lasvegaskidney.bsky.social
Reposted
Finerenone trials
#PSHPLAS 🇵🇭 #Nephpearls #NephSky
👉🏼 FIDELIO pubmed.ncbi.nlm.nih.gov/33264825/
👉🏼 FIGARO pubmed.ncbi.nlm.nih.gov/34449181/
👉🏼 FIDELITY pubmed.ncbi.nlm.nih.gov/35023547/
👉🏼 FINE-HEART pubmed.ncbi.nlm.nih.gov/39218030/
#PSHPLAS 🇵🇭 #Nephpearls #NephSky
👉🏼 FIDELIO pubmed.ncbi.nlm.nih.gov/33264825/
👉🏼 FIGARO pubmed.ncbi.nlm.nih.gov/34449181/
👉🏼 FIDELITY pubmed.ncbi.nlm.nih.gov/35023547/
👉🏼 FINE-HEART pubmed.ncbi.nlm.nih.gov/39218030/
February 28, 2025 at 10:29 AM
Finerenone trials
#PSHPLAS 🇵🇭 #Nephpearls #NephSky
👉🏼 FIDELIO pubmed.ncbi.nlm.nih.gov/33264825/
👉🏼 FIGARO pubmed.ncbi.nlm.nih.gov/34449181/
👉🏼 FIDELITY pubmed.ncbi.nlm.nih.gov/35023547/
👉🏼 FINE-HEART pubmed.ncbi.nlm.nih.gov/39218030/
#PSHPLAS 🇵🇭 #Nephpearls #NephSky
👉🏼 FIDELIO pubmed.ncbi.nlm.nih.gov/33264825/
👉🏼 FIGARO pubmed.ncbi.nlm.nih.gov/34449181/
👉🏼 FIDELITY pubmed.ncbi.nlm.nih.gov/35023547/
👉🏼 FINE-HEART pubmed.ncbi.nlm.nih.gov/39218030/
Reposted
eGFR effects of treatments for IgA nephropathy, from Dr Brad Rovin @glomcon.org
(One of the top 10 stories coming from #NephJC)
(One of the top 10 stories coming from #NephJC)
January 4, 2025 at 12:50 PM
eGFR effects of treatments for IgA nephropathy, from Dr Brad Rovin @glomcon.org
(One of the top 10 stories coming from #NephJC)
(One of the top 10 stories coming from #NephJC)
Reposted
Wondering why vasoconstrictors work in hepatorenal syndrome even though the pathogenesis is driven by renal vasoconstriction? Here is a conceptual explanation:
November 18, 2024 at 7:15 PM
Wondering why vasoconstrictors work in hepatorenal syndrome even though the pathogenesis is driven by renal vasoconstriction? Here is a conceptual explanation: